<?xml version="1.0" encoding="UTF-8"?>
<p>Target Malaria receives core funding from the Bill &amp; Melinda Gates Foundation and from the Open Philanthropy Project Fund, an advised fund of Silicon Valley Community Foundation. The works performed at National Institute of Allergy and Infectious Diseases (NIAID) were supported by Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH.</p>
